Consensus Ginkgo Bioworks Holdings, Inc.

Equities

DNA

US37611X1000

Delayed Nyse Other stock markets 01:00:01 2024-07-03 pm EDT			5-day change	1st Jan Change
0.3755 ^USD	+8.37%		+32.26%	-77.78%

Jun. 28	Microba Life Sciences Completes Screening for Autoimmune Disease Program; Shares Down 3%	MT
May. 30	Transcript : Ginkgo Bioworks Holdings, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-30-2024 10:40 AM

Evolution of the average Target Price on Ginkgo Bioworks Holdings, Inc.

Price target over the last 5 years

History of analyst recommendation changes

b178ce4a7a55b551fbc1a97fcd68b3.3el8A6GX7uTYqSNdo5vMNn9excEuQfdYVf4t56m6kLM.iK0YbdTvmKqy4HQMzPqWe1I0h_hBNqEtEJlpsJvryYepv0p76eGdvLP9Yg~eadf51d00712c10099abd18f5adf53e9

Analyst Recommendations on Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings Insider Bought Shares Worth $514,750, According to a Recent SEC Filing	May. 16	MT
BTIG Downgrades Ginkgo Bioworks Holdings to Sell From Neutral, Price Target is $0.50	May. 15	MT
Morgan Stanley Trims Ginkgo Bioworks Price Target to $1 From $2, Maintains Equal Weight Rating	May. 15	MT
Ginkgo Bioworks Holdings Insider Bought Shares Worth $271,815, According to a Recent SEC Filing	May. 14	MT
Ginkgo Bioworks Holdings Insider Sold Shares Worth $1,606,162, According to a Recent SEC Filing	May. 14	MT
William Blair Downgrades Ginkgo Bioworks Holdings to Underperform From Market Perform	May. 10	MT
TD Cowen Cuts Price Target on Ginkgo Bioworks to $3 From $7, Maintains Outperform Rating	Mar. 01	MT
Goldman Sachs Trims Ginkgo Bioworks Price Target to $1.10 From $1.25, Maintains Sell Rating	Jan. 22	MT
Raymond James Downgrades Ginkgo Bioworks to Market Perform From Outperform, Price Target is $2.50	Nov. 14	MT
BTIG Downgrades Ginkgo Bioworks Holdings to Neutral From Buy	Nov. 09	MT
Goldman Sachs Downgrades Ginkgo Bioworks to Sell From Neutral, Adjusts Price Target to $1.25 From $3	23-06-02	MT
William Blair Downgrades Ginkgo Bioworks Holdings to Market Perform From Outperform	23-05-11	MT
Berenberg Bank Initiates Coverage on Ginkgo Bioworks With Buy Rating, $4 Price Target	22-11-29	MT
Morgan Stanley Starts Ginkgo Bioworks Holdings at Equalweight With $5 Price Target	22-10-04	MT
BTIG Adjusts Price Target on Ginkgo Bioworks Holdings to $6 From $5, Reiterates Buy Rating	22-08-16	MT
Raymond James Adjusts Price Target on Ginkgo Bioworks Holdings to $14.50 From $11.50, Keeps Outperform Rating	22-08-16	MT
Jefferies Adjusts Price Target on Ginkgo Bioworks Holdings to $4.35 From $11.50, Reiterates Buy Rating	22-06-16	MT
BofA Securities Downgrades Ginkgo Bioworks Holdings to Underperform From Neutral, Adjusts Price Target to $3 From $6	22-05-18	MT
Cowen Initiates Ginkgo Bioworks Holdings at Outperform With $12 Price Target	22-03-02	MT
Goldman Sachs Starts Ginkgo Bioworks Holdings at Neutral With $7 Price Target	22-02-23	MT
BofA Securities Starts Ginkgo Bioworks Holdings at Neutral With $6 Price Target	22-02-01	MT
BofA Securities Starts Ginkgo Bioworks Holdings at Buy With $8 Price Target	22-01-28	MT
BTIG Starts Ginkgo Bioworks Holdings at Buy With $12 Price Target	22-01-07	MT
Jefferies Starts Ginkgo Bioworks Holdings at Buy With $16 Price Target	21-11-29	MT
GINKGO BIOWORKS : Raymond James Starts Ginkgo Bioworks Holdings at Outperform with $14.50 Price Target	21-10-13	MT